Ann Albright, PhD, RD, is the Director, Division of Diabetes Translation at the Centers for Disease Control and Prevention. As director, Dr. Albright leads a team of more than 100 who strive to eliminate the preventable burden of diabetes through leadership, research, programs, and policies that translate science into practice. Dr. Albright's current work includes a focus on community and behavioral supports for the prevention and management of diabetes, translation of science into practice, and the collection and analysis of diabetes surveillance data to monitor and guide public health activities. From March 2003- December 2004, Dr. Albright served as the Senior Health Policy Advisor in the Office of the United States Surgeon General and led the Secretary of Health's Diabetes Detection Initiative. She has a doctorate in exercise physiology and is also a registered dietitian. Dr. Albright is the current national president, health care and education for the American Diabetes Association and has lived with type 1 diabetes for 40 years.
Barbara J. Anderson, PhD, is a behavioral scientist and licensed clinical psychologist with 25 years of experience in diabetes research as well as in clinical work with youth with diabetes and their families. She has published extensively on the relationships between emotional and family factors with adherence and medical outcomes in youth with diabetes. Dr. Anderson is currently working with two multi-site NIH-funded trials-one with youth with type 1 and families and the other with youth with type 2 and families. Dr. Anderson is currently Professor of Pediatrics, Baylor College of Medicine, and Senior Psychologist, Diabetes Care Center, Texas Children's Hospital.
Henry Anhalt, DO, FAAP, FACOP, FACE, CDE is the Director, Medical Affairs at Animas Corporation. Prior to his appointment at Animas he was Director, division of pediatric endocrinology and diabetes at the Saint Barnabas Medical Center in New Jersey and at the Infant's and Children's Hospital of Brooklyn at Maimonides Medical Center in Brooklyn. Dr. Anhalt has published widely in both the lay press and the scientific literature on a variety of topics in pediatric endocrinology and diabetes. He serves on the Advocacy and Public Outreach Core Committee of the Endocrine Society and the Public Policy Committee of the Lawson Wilkins Pediatric Endocrine Society. Dr. Anhalt maintains an active clinical practice in Hackensack, NJ and is known as a compassionate leader in diabetes care; he is a certified diabetes educator and champions the use of pump therapy and continuous glucose monitoring technology in all children with diabetes. Dr. Anhalt is a sought after speaker and is often quoted in the Wall St. Journal, LA Times, and CNN. He lectures widely both in the United States and internationally.
Natalie Bellini, R.N., C.D.E., has had diabetes since she was a young child and within a year of finishing nursing school started to care for people with diabetes, first focusing on high risk pregnancy and then pediatrics and insulin-requiring adults. She has lectured both nationally and internationally to clinicians, patients and their families. Natalie has worked with children and adults of all ages and has assisted in initiating and expanding pump programs at numerous hospitals and private practices. She is currently a Clinical Sales Specialist with Ethicon, a division of Johnson and Johnson. She enjoys working with children and teens, and has a second full-time job as mom to her daughter, Erin, who is now in college.
Betty Brackenridge, MS, RD, CDE, Director of Professional Education for Diabetes Management and Training Centers, Inc. (DMTC) of Phoenix, Arizona, is a Past-President of the American Association of Diabetes Educators and served a six-year term on the US Centers for Disease Control's Technical Advisory Committee on Diabetes. She has developed and delivered programs on clinical care and experiential learning in diabetes to health professionals in some 35 countries. She has also authored over 100 publications for both lay persons and professionals, the most recent ones being Draw Wide the Circle of Love: How to Unite Your Family in the Care of a Child with Diabetes and Diabetes Myths, Misconceptions and Big Fat Lies!, the patient text for DMTC's Discovering DiabetesTM adult patient education program. She is also the author, with Kris Swenson, of the Discovering Diabetes program and, with Dr. Richard Rubin, of Sweet Kids, a popular and highly regarded book for families that presents diabetes nutrition and self-care in the context of optimal family functioning. Betty is a long-time friend of Children with Diabetes and is the Coordinator of the Friends for Life Grandparents' Track.
Bruce Buckingham, M.D., received his medical degree from the University of California at San Diego, and did his pediatric and endocrine fellowship at the Children's Hospital of Los Angeles. On becoming an attending at CHLA, he had the pleasure of working with Dr. Fran Kaufman as she started her endocrine fellowship. He subsequently moved to the Children's Hospital of Orange County where he remained for 18 years. While at Orange County he had the opportunity to work with an incredible parent organization, the PADRE foundation. For the last 6 years he has been working at the Stanford Medical Center. He has a long standing interest in glucose sensors, and while at Stanford has conducted a number of studies using the GlucoWatch and Minimed CGMS. He is currently the Principal Investigator at Stanford for the mulitcenter NIH trial (DirecNet) to assess the use of glucose sensors in Children.
Bob Bulgarelli, D.O., is a cardiologist who specializes in Preventative and Integrative Cardiovascular Medicine. Bob is Director of Integrative Cardiovascular Medicine at Main Line Health System in Suburban Philadelphia. Bob is cofounder and Chief Medical Officer of, Mind Body Spirit Inc. MBS is a habit change company that addresses lifestyle change in a holistic manner. The program is geared toward (but not limited to) risk reduction for Cardiac patients, including diet, exercise, stress management, group support and spirituality amongst others. Bob did his formal training in Integrative Medicine and Cardiology with Andrew Weil MD at the University of Arizona. Bob has a particular interest in bringing his message of healthy lifestyle change to children and adolescents, and has been doing so as part of the CWD staff for several years.
H. Peter Chase, MD, is the past Executive and Clinical Director of the Barbara Davis Center for Childhood Diabetes in Denver, Colorado. In addition, he is a Professor of Pediatrics at the University of Colorado Health Sciences Center in Aurora, CO. He is a principal investigator in the multi-center NIH - funded studies of Diabetes Research in Children Network (DirecNet) and the Type 1 Diabetes/TrialNet prevention studies. Dr. Chase has received many honors, including the Outstanding Physician Clinician in Diabetes award from the American Diabetes Association, a Lifetime Achievement Award from JDRF and the Ross Award for Outstanding Research in Pediatrics. He has authored over 200 research papers and 50 textbook chapters, in addition to the 11th edition of Understanding Diabetes.
Anthony T. Cheung, Ph.D., is the co-founder and Chief Scientific Officer of a Vancouver-based biotechnology company, enGene, Inc. He has been actively conducting research in the fields of diabetes and gene therapy for over 15 years. Dr. Cheung and his team were the first to identify a method to genetically engineer specific cells in the gut to produce insulin automatically in subjects with diabetes. This therapeutic strategy was later developed into enGene's platform technology called, Gut Endocrine-cells Modification System (GEMS™). This technology can be applied to induce cells in the intestinal tract to produce a wide range of therapeutic proteins to treat a broad spectrum of diseases. enGene's first product candidate, GEMS™-Insulin, aims to provide an internal and automatic insulin replacement therapy for patients with diabetes. The GEMS™ platform has now broadened to deliver therapeutic cytokines locally to the intestine for Inflammatory Bowel Diseases. enGene was selected as the recipient of the Excellence in Research Award by Frost & Sullivan in 2005.
William Clarke, M.D., is Genentech Professor of Pediatrics and Chief of Pediatric Endocrinology at the University of Virginia in Charlottesville. Dr. Clarke has been involved in diabetes research for the past 30 years and during his fellowship worked with a prototype of an artificial pancreas. His research has been in the areas of improving glucose control in children with T1DM through a better understanding of the clinical accuracy of patient determined blood glucose readings using a variety a mechanisms including self-blood glucose monitors, estimation, and continuous glucose sensors. He, along with colleagues in Behavioral Medicine, has been involved in developing and testing a psycho-behavioral intervention, "Blood Glucose Awareness Training," which can help people improve their glucose estimation and reduce episodes of severe hypoglycemia, DKA, and auto accidents. He has also worked with a driving simulator to better understand the effects of low blood glucose on driving performance and has recently been involved with studies to understand how parents and children co-regulate T1DM. He is the past recipient of the American Diabetes Association's "Outstanding Contribution to Diabetes in Youth" and is currently a member of the ADA's "Safe at School" Task Force. Dr. Clarke's diabetes practice includes over 500 children and their families.
Chris Dudley is the president and founder of The Dudley Foundation, which is dedicated to kids and diabetes and provides educational programs, advocacy, and supports diabetes research. Through the foundation, he also established the only basketball camp in the country for children with diabetes – the Chris Dudley Basketball Camp for Kids with Diabetes -- outside of Portland, Oregon. A former NBA Center, Dudley spent 16 years playing for the Cleveland Cavaliers, New Jersey Nets, Portland Trailblazers and the New York Knicks. Dudley excelled at Yale University by earning degrees in economics and political science, and becoming only the sixth basketball player at Yale to be drafted into the NBA. Dudley and his wife, Christine, have three children.
Edward Damiano, Ph.D., is an Associate Professor of Biomedical Engineering at Boston University. His educational training is in the areas of biomedical and mechanical engineering and applied mathematics. His lab is engaged in basic scientific research that uses fluid dynamics, solid mechanics, and intravital microscopy to study blood flow in the microcirculation and to elucidate mechanisms by which the lining of blood vessels can determine vascular health and disease. In one study, his lab is investigating the effect of hyperglycemia in diabetic mice with the goal of finding ways to counteract the damage to blood vessels that leads to so many of the well-known complications of diabetes. In addition to this research, he is also committed to creating and integrating closed-loop blood-glucose control technologies. His interest in closed-loop control is quite personal, and began when his seven-year-old son, David, developed type 1 diabetes at the age of one. A goal of his is to have the control algorithm that was developed by one of his postdoctoral fellows, Dr. Firas El-Khatib, hard at work closing the loop for people with diabetes before David starts high school.
Larry C. Deeb, M.D. is a pediatric endocrinologist in private practice in Tallahassee, Florida. He is also Director for the Diabetes Center at Tallahassee Memorial Hospital and Clinical Professor of Pediatrics at the University of Florida as well as Clinical Professor of Behavioral and Social Medicine at Florida State University. He is the immediate past president for medicine and science of the American Diabetes Association. Dr. Deeb received both his Bachelor's degree in History and his Medical degree from Emory University. He completed his internship, residency, and fellowship in pediatric endocrinology at the University of Minnesota. In addition to his research, Dr. Deeb is the International Diabetes Federation's Chair of the Task Force for Insulin and Diabetes Supplies. As a very active and committed member of Rotary International he has worked to establish diabetes clinics in South America, Africa, and Southeast Asia. This is in collaboration with IDF's Life for a Child Program.
Alessio Fasano, M.D., Professor of Pediatrics and Director, Pediatric Gastroenterology and Nutrition, and Co-Director of the Center for Celiac Research at the University of Maryland School of Medicine. He is also Professor of Physiology and Professor of Medicine. Dr. Fasano is regarded as one of the foremost authorities worldwide on Celiac Disease, and his epidemiological studies in the United States have changed the preconception that Celiac Disease is a rare disorder in our county. He will be presenting two sessions on celiac disease, which is more common in children with type 1 diabetes than the general population.
Lynda K. Fisher, MD, Associate Professor of Pediatrics, The Keck School of Medicine of the University of Southern California, Associate Head, The Center for Endocrinology, Diabetes and Metabolism at Children's Hospital Los Angeles, is the Treasurer of the International Society for Adolescent and Pediatric Diabetes. She has served on the Board of Directors of the American Diabetes Association as well as many ADA national committees and task forces (especially those focused on youth and advocacy). She has been very active in advocacy for children with diabetes on the local, state, national and international arenas. She spends time each summer as a medical director at diabetes camps in California.
David M. Harlan, M.D., is the Chief, Islet and Autoimmunity Branch of the National Institute of Diabetes, Digestive, and Kidney Diseases at the National Institutes of Health of the Department of Health and Human Services. He is also a Captain in the U.S. Public Health Service, and a Professor of Medicine at the Uniformed Service University of the Health Sciences. Dr. Harlan has explored the immunopathological mechanisms underlying type 1 diabetes mellitus (T1DM) for over 15 years, with studies spanning a range from test tube experiments, to animal model research, and to clinical trials. His focus in all that work has been the same however; to find ways to prevent T1DM for those at risk, and to ameliorate - or better - cure it for those already diagnosed. Dr. Harlan is the recipient of several honors and awards, is a sought after speaker, and has published more than 90 scientific manuscripts and chapters.
Crystal Jackson is Associate Director of Legal Advocacy at the American Diabetes Association (ADA)'s National Office in Alexandria, Virginia. Her primary responsibility is managing the Association's Safe at School Campaign. Crystal is considered a national authority on the rights of students with diabetes and has spoken at conferences and forums throughout the United States and internationally on how to effectively advocate on behalf of students with diabetes, training hundreds of parent advocates, attorneys, and health care professionals. A parent of a child with diabetes, Crystal began her advocacy as a volunteer for ADA when she and another parent advocate teamed up to pass the first state diabetes school legislation in the country which provides comprehensive coverage for students with diabetes in Virginia. Simultaneously she pursued a complaint with the Office of Civil Rights of the Department of Education resulting in a settlement that is a model for safe and effective diabetes care. Crystal is a former litigation paralegal with the Philadelphia law firm of Fox, Rothschild, O'Brien & Frankel. She is a contributor to many diabetes publications including the U.S. Department of Health and Human Services National Diabetes Education Program's school guide entitled "Helping the Student with Diabetes Succeed: A Guide for School Personnel" and the ADA's treatise on school issues: "Legal Rights of Students with Diabetes." Crystal is a member of the Virginia Diabetes Council, serves on a number of other diabetes and youth advisory boards, and was most recently appointed to Novo Nordisk's U. S. DAWN Youth Study Advisory Board. She resides in Loudoun County, VA with her family.
Nicole Johnson, MA, MPH, Miss America 1999 works on diabetes advocacy and education worldwide. She was diagnosed with type 1 diabetes at 19 while a sophomore at the University of South Florida. Since that time, Nicole has formed a consulting company and foundation that focus on diabetes education and the public health impact of the disease. Her passions include diabetes research and pregnancy and diabetes. Nicole and her daughter Ava have participated in numerous diabetes research studies to try to learn about genetics and the family impact of disease. Nicole is also the host of dLIfeTV on CNBC and writes monthly columns for numerous publications on Diabetes reality. She has been attending CWD conferences since 2000.
Francine Ratner Kaufman, MD, has had a 30 year distinguished career in the field of diabetes. In May, 2009, she became the Chief Medical Officer and Vice President of Global Clinical Diabetes for Medtronic Diabetes (Northridge, California). She is an Emeritus Professor of Pediatrics and Communications at the Keck School of Medicine and the Annenberg School of Communications of the University of Southern California, and an attending physician at Children's Hospital Los Angeles. Dr. Kaufman has published more than 200 scientific articles and authored of 30 books or book chapters. In 2008, she edited the 5th edition of the ADA's The Medical Management of Type 1 Diabetes. In 2005 her book, Diabesity, was published by Bantam. Dr. Kaufman was national president of the American Diabetes Association in 2002-03. She served as chair of the Youth Consultative Section of the International Diabetes Federation. In 2007, she was Co-Chair of the Diabetes Work Group for the Department of Health Services of the State of California. In 2005, she was elected to the Institute of Medicine. In 2007, Dr. Kaufman filmed a documentary for Discovery Health on the global diabetes epidemic.
Kim Kelly, Pharm. D., BCPS, FCCP, is Director of the Johnson & Johnson Diabetes Institute, North America. Dr. Kelly has a lengthy and distinguished career involving patient care, academic medicine, and organizational involvement including President of the American College of Clinical Pharmacy, Chairman of the ACCP Research Institute, and Board of Directors of the Diabetes Exercise and Sports Association. His research and experience have included a number of publications, participation on editorial boards and review panels of several journals, involvement in medical curriculum development, and various committees of professional organizations. Currently, his activities center around developing diabetes health management and educational programs for various health care providers and provider organizations. Delighted to work with children and teens alike, Dr. Kelly participated as a volunteer in the Orlando and Universal City Friends for Life conferences, where he became 'hooked' in working with the wonderful CWD kids and families. He joined CWD as 'regular faculty' in 2004, focusing on the Tween programming and providing presentations on various topics to parents as well.
Norma Sue Kenyon, Ph.D., is the Martin Kleiman Professor of Surgery, Medicine, Microbiology and Immunology at the University of Miami Miller School of Medicine, and Associate Director of Research and Program Development, Director of Pre-Clinical Islet Transplantation, and Director of the Wallace H. Coulter Center for Translational Research at the Diabetes Research Institute. Dr. Kenyon has concentrated her work in the area of transplant immunology, identifying the types of cells in the immune system that either enhance or inhibit the rejection process, and translating these findings into new therapies for patients. An established leader in islet transplantation in pre-clinical models, Dr. Kenyon's results have sparked great enthusiasm within the scientific community, and have been published in a number of peer-reviewed journals. She and her team have focused on ways to transplant islets without the need for anti-rejection drugs (tolerance), and have conducted numerous studies using bone marrow and other methods to help recipients tolerate transplanted tissue. In addition, the team is now looking at agents that limit early loss of islets post-transplant, thereby decreasing the numbers of islets required to achieve insulin independence.
Paul B. Madden, M.Ed., is a family counselor, diabetes educator, business developer, program manager, fundraiser and advocate for people living with and at risk of diabetes. He has served in numerous leadership positions, most recently as the Director, Professional Relations & Public Advocacy for the Johnson & Johnson Family of Companies. Paul has chaired several national and international meetings for professionals, parents, and young people with diabetes. Paul leads advocacy issues, opens business doors and nurtures relationships to gain maximum opportunities to help ensure more focused, successful efforts for people living with diabetes and the professionals, organizations and companies supporting diabetes care and research. He touches the soul of living with diabetes for patients, their families and their professionals.
Amany Maher, MD, received her medical degree from Cairo University, Egypt. She is a member of the Sweet Kidz Group in Dubai, United Arab Emirates. Within this support network for people with type 1 diabetes, Amany interacts with and supports a diverse group of individuals with diabetes. Her role includes providing comprehensive diabetes education and empowering individuals to succeed with insulin pump therapy. Amany is known for her caring attitude and genuine concern for all her patients, and for her active involvement in the diabetes community. This is her second Friends for Life conference, and her first as faculty.
Kenneth P. Moritsugu, MD, MPH, FACPM joined the Johnson & Johnson Family of Companies in October 2007. Serving as Chairman of the Johnson & Johnson Diabetes Institute, he will develop innovative programs and strategies that will help Johnson & Johnson companies and the health care community better address the delivery of diabetes care around the world. Born in Hawaii, Dr. Moritsugu achieved Admiralty status within the Commissioned Corps of the U.S. Public Health Service, was the Federal representative to numerous national health care agencies and consulted with several international organizations and governments. Before serving as Acting Surgeon General in 2006, Dr. Moritsugu was the Deputy Surgeon General and the principal assistant and advisor to the U.S. Surgeon General for nearly ten years. Having completed residencies in internal medicine and in preventive medicine, Dr. Moritsugu is Board Certified in preventive medicine and holds Fellowships in the American College of Preventive Medicine, the Royal Society of Health, and the Royal Society of Medicine. Dr. Moritsugu has Type 1 diabetes and appreciates the many challenges facing patients -- and diabetes professionals -- today.
Rick Philbin, MED, MBA, ATC, is the East Field Director for Animas Corporation, an athletic trainer, and an individual with Type 1 diabetes. Prior to joining Animas, he managed a comprehensive sports medicine center in the Washington, DC area. He is currently on the board of directors of the Diabetes, Exercise, and Sports Association (DESA), a non-profit organization whose mission is to enhance the quality of life for people with diabetes through exercise and physical fitness. Rick has been working with CWD for seven years presenting to parents, coordinating the sports programming for kids, and writing articles on the CWD website called the Sports Corner. Rick's professional experience also includes working as an Athletic Trainer for a Philadelphia-based sports medicine center, where he worked with professional athletes from the Philadelphia 76ers and Flyers. He believes education is paramount for good diabetes management. As an avid exercise enthusiast with Type 1 diabetes, he practices tight management of his diabetes while on an insulin pump. Rick lives in the Washington, DC area.
Arleen Pinkos, MT, ASCP, has worked as a clinical review scientist at the Food and Drug Administration since 1993. She has a Bachelor of Science degree in Medical Technology from Indiana University of Pennsylvania. Arleen has worked as a laboratorian and point-of-care testing coordinator at Veterans Administration Medical Centers in New Jersey and Maryland, consulted for physician office laboratories, and has managed a private physician referral service. Arleen has worked extensively with over-the-counter products at the FDA, including glucose meters and Continuous Glucose Monitors. She is also coordinating the FDA-NIH Artificial Pancreas Working Group.
Richard Rubin, Ph.D., C.D.E., Psychologist, past president of the American Diabetes Association, and Professor in Medicine and Pediatrics, Johns Hopkins School of Medicine, Baltimore, Maryland. Author of Psyching Out Diabetes and Sweet Kids, Optimal Pumping, and 101 Tips for Coping with Diabetes, Dr. Rubin is Stefan Rubin's father. Stefan is also on the conference faculty and is a co-author of Optimal Pumping and 101 Tips for Coping with Diabetes. Dr. Rubin is a sought after speaker for both professionals and people living with diabetes. He speaks with authority and warmth on the human side of diabetes.
Stefan Rubin was diagnosed type 1 in 1979, at the age of seven and began insulin pump therapy three years later. He considers his experience an invaluable exercise and education that continue to prepare him for any hurdles that diabetes-and-life place in his path. Long a source of inspiration for his father, Dr. Richard R. Rubin, Stefan is co-author of two books, including 101 Tips for Coping with Diabetes, published in 2003 by the American Diabetes Association. Stefan also speaks locally and nationally in an ongoing attempt to share his outlook on living well with diabetes. Stefan and his wife Christine, live, work and play with their son Brooks and daughter Maisie in Baltimore, Maryland.
Gary Scheiner, MS, CDE, having had type 1 diabetes since 1985 and working as a Certified Diabetes Educator since 1993, knows the latest and best techniques for achieving optimal diabetes control. In addition to serving on the Board of Directors of the Juvenile Diabetes Research Foundation, Gary has authored a book and dozens of articles, and speaks at local and national meetings on diabetes, fitness and motivation. Gary received the 1997 William Martin Award for Outstanding Achievement in Patient Activities by the American Diabetes Association, as well as the 1998 Allene Van Son Award for the development of effective diabetes teaching tools by the American Association of Diabetes Educators. In 2002, he was granted the Novo Nordisk Diabetes Education Research award for the study of basal insulin levels in pump users. Gary owns and operates Integrated Diabetes Services, a private practice located just outside of Philadelphia, specializing in intensive blood glucose control and lifestyle intervention for people with diabetes.
Scott K. Scolnick, MEd, is the Regional Manager for the SE US with Animas Corporation. He has had type 1 diabetes since 1975. Scott has been on a pump since 1996. Prior to his work with Animas, Scott received his Masters in Counseling Psychology and has Post Masters Training in Marriage and Family Therapy. He was a marriage and family therapist from 1985-1988. Scott developed and ran Child Adolescent Inpatient and Community based treatment programs from 1988-2000 in Virginia, Indianapolis, Texas, New Mexico, Greater Philadelphia area and Upstate New York. He specializes in using creativity and the imagination in problem solving and decision making. Scott believes in the ideas of empowerment and catching people doing right. He likes to challenge the way in which people think and act in order to help people thrive with diabetes.
Joe Solowiejczyk, RN, MSW, was President of InBalance Healthcare, a counseling and education service for health care professionals and adults and children with diabetes, for over 10 years. For the past 3 years he worked for the Animas Corporation as Clinical Manager of Counseling & Presentations. In this capacity, he presented nationally on The Family Approach, saw patients and their families in key accounts as well as providing training and supervision for clinicians interested in learning about The Family Approach. Most recently he was invited to be on the faculty at the Johnson & Johnson Diabetes Institute and transitioned over to LifeScan, working with the Global Strategic Affairs Group. A healthcare professional who has lived with Type 1 diabetes for over 40 years, Mr. Solowiejczyk has been able to translate his personal experience into patient care. As a diabetes nurse educator and family therapist, he specializes in assessing how family dynamics impact management of diabetes and designing interventions that result in more effective coping and optimal metabolic control.
Cherie Stabler, Ph.D., is an Assistant Professor of Biomedical Engineering at the University of Miami School of Engineering and Director of the Tissue Engineering Laboratory at the Diabetes Research Institute. Her research interests are concentrated in the areas of tissue engineering, biomaterials, and noninvasive monitoring. Specifically, Dr. Stabler's research focuses on the design and development of various islet encapsulation techniques and evaluating how these barriers can protect the islets against the vigorous immunological and inflammatory responses of the host. In addition, she is investigating the application of conjugation techniques to tether agents to polymer layers in order to generate implants capable of "actively" modulating the interaction between the host and implanted cells. Dr. Stabler has a background in both chemical and biomedical engineering. She received her doctoral degree from the Georgia Institute of Technology/Emory University Department of Biomedical Engineering.
John Walsh, PA, CDE is a Physician Assistant and Diabetes Clinical Specialist who has provided clinical care for patients with diabetes for 25 years. He specializes in diabetes care for people on pumps. He is co-author of Pumping Insulin, now in its fourth edition, Using Insulin, STOP the Rollercoaster, and The Pocket Pancreas. President of Diabetes Mall, he is also webmaster of diabetesnet.com, a highly trafficked source of diabetes information and technology visited by 6,000 people a day. John is a consultant for medical corporations and a frequent speaker on pump therapy, diabetes therapy, intensive diabetes management, and the future of smart pumps, meters and continuous monitors. John has worn a wide variety of insulin pumps for the last 23 years.
Stuart Weinzimer, MD, FAAP, is Associate Professor of Pediatrics at the Yale School of Medicine. He earned his bachelor's degree in molecular biochemistry and biochemistry at Yale University, and his medical degree at the Albert Einstein College of Medicine. He completed his residency and pediatric endocrinology training at the Children's Hospital of Philadelphia. Dr. Weinzimer has focused his clinical and research on the application of continuous glucose sensors and insulin pumps in children with type 1 diabetes and the development of an artificial pancreas. He is the Principal Investigator of a Juvenile Diabetes Research Foundation-funded study of an artificial pancreas for children with diabetes, and Principal Investigator at the Yale site for two multi-center studies of continuous glucose sensors. He and his wife, Jodie Ambrosino, PhD, who is a pediatric health psychologist studying stress and coping in families of children with diabetes, have two girls, Rebecca, age 10, and Eliana, age 2.
Barb Whedon, MS, RD, CDE, graduated from Penn State and KU with degrees in nutrition. She has over 20 years experience as a nutrition and diabetes educator and has been employed by Animas for the past six years. Barb has loved working with the families and staff of Children's Hospital of Philadelphia, Camp Greenlane, and CWD.
Friends for Life 2008 Conference and Expo Introduction - Registration - FAQs - Special Guests Faculty - Youth Faculty - CWD Staff - 5000 Step Club First Timer Hospitality - Teen Welcome Group - Grandparents Program Overview - Parents & Adults - Youth - Focus Groups - Suggestions - Social Events Sponsors & Partners - Exhibitors - Attendees - Hotel Floor Plan - Bus Schedule FFL Reports from 2007 - 2006 - 2005 - 2004 - 2003 - 2002 - 2001
|Return to the Top of This Page|
Last Updated: (none)
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.